Clinical Trials Directory

Trials / Completed

CompletedNCT05025943

Omega-3 Fatty Acid Dietary Intervention (O3DI)

Omega-3 Fatty Acid Dietary Intervention for Dyslipidemia of Obesity in Children 10 to <18 Years of Age: O3DI Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
Nemours Children's Clinic · Academic / Other
Sex
All
Age
10 Years – 17 Years
Healthy volunteers
Not accepted

Summary

Elevated cholesterol, including triglyceride levels, can lead to the development of cardiovascular disease in adulthood. A diet that is rich in omega-3 fatty acids (O3FA) can improve triglyceride levels in a way that is safe and does not require medication. This is a single-center, prospective, unblinded, randomized-controlled dietary intervention study to assess the impact of an omega-3 fatty acid diet compared to a standard lifestyle intervention on serum triglyceride in patients with hypertriglyceridemia. The study consists of an 8-week dietary treatment period followed by an 8-week observation period.

Conditions

Interventions

TypeNameDescription
OTHERDiet interventionThe intervention group will receive diet counseling and information to implement a standard lifestyle intervention plus omega-3 fatty acid enriched foods Diet assessment and counseling provided throughout study.
OTHERControl groupThe control group will receive diet counseling and information to implement a standard lifestyle intervention Diet assessment and counseling provided throughout study.

Timeline

Start date
2021-08-16
Primary completion
2022-09-07
Completion
2023-03-15
First posted
2021-08-30
Last updated
2023-03-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05025943. Inclusion in this directory is not an endorsement.

Omega-3 Fatty Acid Dietary Intervention (O3DI) (NCT05025943) · Clinical Trials Directory